Hyperthyroidism in Pregnancy: Graves Disease, PTU vs Methimazole

• Hyperthyroidism in pregnancy is uncommon (about 0.1-0.4%), and Graves disease is the usual persistent cause.
• Graves disease must be separated from transient gestational thyrotoxicosis, which is driven by high hCG in early pregnancy and usually settles by the second trimester without antithyroid drugs.
• PTU (propylthiouracil) is preferred in the first trimester; most specialists switch to methimazole from the second trimester to lower maternal liver risk.
• The goal is the lowest effective dose that keeps free T4 in the upper-normal range, not to push thyroid levels low, because overtreatment can affect the baby's thyroid.
• Graves pregnancy is best managed jointly by an obstetrician and an endocrinologist, with TRAb antibody testing to estimate fetal risk.
• Thyroid storm is a rare emergency: fever, very fast heartbeat, vomiting, confusion and agitation need urgent hospital care.

Hyperthyroidism means the thyroid gland is making too much hormone, so the body runs faster than it should. In pregnancy it is uncommon, affecting roughly 0.1 to 0.4 percent of pregnancies, but it matters because uncontrolled disease can affect maternal health, placental function and the baby's growth. It is not simply a number on a lab report. It is a clinical condition that needs correct diagnosis and follow-up.

In Indian pregnancy practice, the most common persistent cause is Graves disease, an autoimmune condition in which antibodies stimulate the thyroid and keep it overactive. Because these antibodies can cross the placenta, management is not only about the mother. It also aims to protect the baby and newborn.

The reassuring part is that careful treatment usually leads to good outcomes. The aim is to control excess thyroid hormone with the lowest effective dose, monitor mother and baby regularly, and avoid both undertreatment and overtreatment. This is the opposite of an underactive thyroid; if your reports point the other way, our guide to hypothyroidism in Indian women explains that picture.

Not every pregnant woman with a suppressed TSH has Graves disease. Transient gestational thyrotoxicosis is driven by very high hCG levels in early pregnancy, especially with severe vomiting, twins or a molar pregnancy. It usually appears in the first trimester and improves by the second trimester as hCG falls, often without any antithyroid medicine.

Graves disease behaves differently. It is caused by thyroid-stimulating antibodies, often called TRAb, and tends to persist beyond the first trimester unless treated. Women may have a previous thyroid history, a visible goitre, eye signs, or ongoing symptoms even after early nausea settles. A positive TRAb test is the main lab clue that supports Graves.

This distinction is the heart of safe care. Transient thyrotoxicosis usually needs supportive care, and overtreating it can push thyroid levels too low. Graves disease, in contrast, usually needs medication and closer fetal surveillance. When the trigger is a molar pregnancy, the thyroid usually settles once the pregnancy tissue is treated.

Many symptoms of an overactive thyroid overlap with normal pregnancy changes, which is why the pattern and severity matter more than any single sign. Watch for symptoms that feel out of proportion or keep getting worse.

A visible goitre or eye signs such as a staring look or bulging eyes point more specifically towards Graves disease, because these are less likely to come from ordinary pregnancy alone. A past history of thyroid disease, treatment, or relapse after stopping medicine also raises suspicion.

Persistent severe vomiting can be another signal, especially with a very low TSH and high T4. In that situation doctors must separate Graves disease from hCG-related thyrotoxicosis, and also consider hyperemesis gravidarum. Fast or pounding heartbeats are common with an overactive thyroid; our guide to pregnancy heart palpitations explains when that needs checking.

Poorly controlled hyperthyroidism raises the risk of Miscarriage: Types, Recovery and Care in India, preterm birth, pregnancy-induced hypertension and Preeclampsia in Pregnancy: High BP, Warning Signs and Care. It can also worsen maternal weight loss, dehydration and heart strain. Even when symptoms feel tolerable, ongoing thyroid hormone excess can still affect the pregnancy.

For the baby, risks include fetal growth restriction, low birth weight, and rarely fetal or neonatal thyrotoxicosis if maternal TRAb levels are high. This is one reason antibody testing matters in Graves disease. The important message is that uncontrolled disease itself is often more dangerous than well-chosen treatment.

The most severe maternal complication is thyroid storm, a rare but life-threatening emergency marked by extreme overactivity, fever, a very fast heartbeat, vomiting and agitation. Prompt treatment greatly reduces the danger, so the red-flag symptoms below should never be watched at home for long.

The starting point is thyroid function testing. A strongly suppressed TSH, often below 0.1 mIU/L, with elevated free T4 or total T4 supports hyperthyroidism. In India, TSH and T4 testing commonly costs about Rs 300 to Rs 800 depending on the lab and city. Results should always be read using pregnancy-specific reference ranges, not the usual non-pregnant ones, as explained in our trimester-wise TSH guide.

TRAb antibody testing helps confirm Graves disease and estimate fetal risk. In Indian private labs it is often around Rs 2,000 to Rs 4,000. Physical examination also matters: doctors check for goitre, tremor, pulse rate, blood pressure, weight trend and eye findings.

A thyroid ultrasound may help when the gland structure needs review and usually costs around Rs 600 to Rs 1,500. Importantly, radioactive iodine scans are contraindicated in pregnancy and must not be done. Diagnosis is built from history, examination, blood tests and pregnancy-safe imaging only.

In the first trimester, PTU (propylthiouracil) is usually preferred because methimazole has a small but recognised association with specific birth defects when exposure happens during early organ formation. A common Indian starting dose for mild to moderate disease is about 100 to 150 mg a day, adjusted to severity and lab results.

From the second trimester onward, most specialists switch from PTU to methimazole because it is effective and carries a lower risk of serious maternal liver toxicity. In India, methimazole or carbimazole-based options such as Neo-Mercazole are commonly used. The principle is to switch after organ formation is complete while keeping hormone control steady.

Across all trimesters the goal is the lowest effective dose. Doctors aim to keep maternal free T4 in the upper-normal range, not low, because overtreatment can cause fetal hypothyroidism or goitre. Dose changes follow blood tests and symptoms, never guesswork, which is why you should not adjust or stop your dose on your own.

Treatment starts with the lowest dose that controls symptoms and brings T4 toward the upper-normal range. PTU 100 to 150 mg daily is a common early-pregnancy starting range, while methimazole is often used later at about 5 to 15 mg daily depending on disease activity. The exact dose varies with severity and previous treatment.

Monitoring is usually monthly with TSH and T4, especially after starting therapy or changing the dose. TSH often lags behind improvement, so dose decisions should not be based on TSH alone. The target is steady control without tipping the mother or baby toward an underactive thyroid.

In India, generic PTU often costs about Rs 150 to Rs 400 a month, and methimazole or Neo-Mercazole around Rs 100 to Rs 300 a month. Regular lab monitoring adds to the cost, but it is central to safe treatment and usually prevents bigger, costlier complications later.

Pregnancy with Graves disease should generally be treated as high-risk, especially when the diagnosis is new, symptoms are marked, TRAb is positive, or medication doses are changing. The safest setup is joint care between an obstetrician and an endocrinologist, which reduces delays in balancing maternal control with fetal safety.

In India, endocrinology and high-risk obstetric services are available at tertiary centres such as AIIMS, Apollo and Fortis. A specialist consultation often ranges from about Rs 800 to Rs 3,000 depending on the city and hospital, and is worthwhile when the diagnosis is uncertain or complications are suspected.

Indian practice usually follows ICMR, FOGSI and Indian Thyroid Society guidance, alongside international bodies such as the American Thyroid Association. The practical takeaway is simple: do not manage persistent pregnancy hyperthyroidism with isolated lab follow-up alone. Specialist review improves dosing decisions and escalation planning. If you became pregnant after fertility treatment, our guide to thyroid and fertility explains how thyroid care continues into pregnancy.

Beta-blockers are sometimes added for short-term symptom relief while antithyroid medicine starts working. They help when palpitations, tremor or severe adrenergic symptoms are distressing. Propranolol is the usual choice, often around 20 to 40 mg a day in divided doses depending on the symptom burden.

The rule is the lowest dose for the shortest duration. Beta-blockers ease symptoms quickly but do not treat the thyroid cause itself. Once antithyroid drugs take effect, propranolol is usually reduced or stopped rather than continued routinely.

Atenolol is generally avoided in pregnancy because of a stronger association with fetal growth restriction. In India, propranolol brands such as Inderal are widely available and often cost about Rs 50 to Rs 150 a month, but they should still be used only under a doctor's supervision.

Thyroid storm is rare, but it is a true obstetric and endocrine emergency. Warning signs include fever, marked agitation, severe vomiting, confusion, dehydration and a very fast heart rate, often above 140 beats per minute. These symptoms can escalate quickly and must not be managed with home rest or phone advice alone.

In India, calling the 108 ambulance service is the right move if thyroid storm is suspected. Hospital care usually means ICU-level monitoring, fluids and rapid combination treatment, and maternal stabilisation comes first because the baby's safety depends on it.

Treatment commonly includes PTU, iodine started after antithyroid therapy is on board, a beta-blocker and steroids, along with supportive care and treatment of triggers such as infection. The key point is speed: delay can be life-threatening for both mother and baby.

Graves disease often flares again in the weeks after delivery, so your medicine dose may need to be reviewed and increased postpartum. This is a different pattern from postpartum thyroiditis, a separate condition that can be mistaken for ordinary new-mother fatigue, so do not assume your old diagnosis explains every symptom.

If your TRAb levels were high, your baby will be watched for signs of neonatal thyrotoxicosis in the first days and weeks. India's newborn screening heel-prick test checks thyroid status among other conditions and supports early detection.

Both PTU and methimazole are considered compatible with breastfeeding at the usual doses, so a Graves diagnosis is rarely a reason to avoid nursing. Confirm your specific dose with your doctor and continue your scheduled thyroid tests.

Book a prompt review with your obstetrician or endocrinologist if you have a low TSH with symptoms, a new neck swelling, eye changes, or fast heartbeats that do not settle. Do not stop or change your antithyroid medicine on your own, even if you feel better.

Seek emergency care (call 108) if you develop the warning signs of thyroid storm.

• American Thyroid Association: Guidelines for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
• ACOG: Thyroid Disease in Pregnancy (Practice Bulletin)
• NHS: Overactive thyroid (hyperthyroidism)
• Indian Thyroid Society / Endocrine Society of India resources